Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Solifenacin vs Tolterodine in OAB (STAR)
NCT00802373Phase 3Completed
- Sponsor
- Astellas Pharma
- Start
- Jul 2003
- Primary completion
- Oct 2004
- Modality
- Orthosteric Ligands
- Countries
- 17
01
Overview
A Phase 3 trial of solifenacin in overactive bladder (OAB), sponsored by Astellas Pharma. Started Jul 2003; status: completed.
02
Drugs
solifenacin
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT00802373.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00802373.